Stocks / PCRX
Stock profile · 銘柄

Pacira BioSciences, Inc. - Common Stock (PCRX)

PCRX did not make Shishin's board on 2026-07-14: below the liquidity floor (under about $20M traded/day). This is a mechanical screen result, not a view on the company. The figures below are research data, the mechanical screen result and the momentum, trend, and volatility indicators the engines observe, not investment advice.

Shishin's live daily signals are published each morning on the rankings board.

Shishin Score61
In today's boardNo
SetupAPPROACHING
Last close$25.54
SectorPharmaceuticals
Today's scan · 2026-07-14
Not screenedComposite 61/100

PCRX did not make Shishin's board on 2026-07-14: below the liquidity floor (under about $20M traded/day). This is a mechanical screen result, not a view on the company.

Position
100
Thrust
49
Breakout
60
Base
56
Volatility
30
Liquidity
30
Indicators · as of 2026-07-14
ADR · 20d3.7%
ATR · 143.5%
RSI · 1465
Return · 30d+8%
Return · 60d+9%
Above MA205%
Above MA507%
Range · 20d21%
MA stack3
From 52w high-8%
$ Vol · 30d$4M
Vol ratio0.95×
Frequently asked

Is PCRX a Shishin signal?

On 2026-07-14, PCRX is not in Shishin's board. Below the liquidity floor (under about $20M traded/day). This is a mechanical screen result, not a recommendation.

What is PCRX's Shishin momentum score?

As of 2026-07-14, PCRX's composite momentum score is 61/100, a weighted blend of momentum, trend, and volatility indicators on a 0 to 100 scale.

Why didn't PCRX make the board?

Below the liquidity floor (under about $20M traded/day). Shishin's board takes only the names that clear its liquidity, trend, and score thresholds for the active market regime.

Research data, not investment advice. Shishin publishes what its systematic engines observe; it does not recommend buying or selling any security, and is not a registered investment adviser or broker-dealer. See our risk disclosure.

Today's full rankings →Rate your watchlist →All covered stocks →